Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
E.W. Scripps
SSP
$320M
| $1.88M | ﹤0.01% |
122,877
-231,519
| -65% | -$4.33M |
|
4427
PUT
Tucows
TCX
$126M
| $1.88M | ﹤0.01% |
30,800
+19,300
| +168% | +$1.39M |
|
|
TRUE
4428
DELISTED
TrueCar
TRUE
| $1.88M | ﹤0.01% |
343,854
+158,899
| +86% | +$974K |
|
|
ARCH
4429
PUT
DELISTED
Arch Resources, Inc.
ARCH
| $1.88M | ﹤0.01% |
19,900
-7,400
| -27% | -$678K |
|
4430
CALL
Booz Allen Hamilton
BAH
$9.32B
| $1.87M | ﹤0.01% |
28,300
+14,600
| +107% | +$898K |
|
4431
CALL
Methanex
MEOH
$4.34B
| $1.87M | ﹤0.01% |
41,200
+12,700
| +45% | +$637K |
|
4432
CALL
ProShares UltraShort Yen
YCS
$30M
| $1.87M | ﹤0.01% |
102,000
+39,200
| +62% | +$743K |
|
|
TVRD
4433
CALL
Tvardi Therapeutics
TVRD
$25.3M
| $1.87M | ﹤0.01% |
2,419
+769
| +47% | +$540K |
|
|
PDCO
4434
CALL
DELISTED
Patterson Companies, Inc.
PDCO
| $1.87M | ﹤0.01% |
81,800
+27,600
| +51% | +$613K |
|
|
LFC
4435
DELISTED
China Life Insurance Company Ltd.
LFC
| $1.87M | ﹤0.01% |
151,455
+28,801
| +23% | +$366K |
|
4436
PUT
B&G Foods
BGS
$294M
| $1.87M | ﹤0.01% |
90,000
+17,900
| +25% | +$413K |
|
4437
CALL
StoneCo
STNE
$2.32B
| $1.87M | ﹤0.01% |
63,300
-133,500
| -68% | -$3.93M |
|
4438
Digital Turbine
APPS
$1.51B
| $1.87M | ﹤0.01% |
374,277
+277,631
| +287% | +$1.12M |
|
4439
CALL
Dine Brands
DIN
$447M
| $1.87M | ﹤0.01% |
19,600
-3,800
| -16% | -$347K |
|
4440
Nutrien
NTR
$32.6B
| $1.87M | ﹤0.01% |
34,969
-54,269
| -61% | -$2.83M |
|
4441
CALL
Evolent Health
EVH
$529M
| $1.87M | ﹤0.01% |
235,000
-40,000
| -15% | -$474K |
|
|
TBRG
4442
DELISTED
TruBridge
TBRG
| $1.87M | ﹤0.01% |
67,222
-39,063
| -37% | -$1.09M |
|
4443
CALL
Dycom Industries
DY
$12.6B
| $1.87M | ﹤0.01% |
31,700
-52,400
| -62% | -$2.68M |
|
4444
Intuitive Surgical
ISRG
$139B
| $1.86M | ﹤0.01% |
10,668
-1,528,173
| -99% | -$262M |
|
4445
Algonquin Power & Utilities
AQN
$4.53B
| $1.86M | ﹤0.01% |
153,591
-82,111
| -35% | -$960K |
|
4446
PUT
CACI
CACI
$14.8B
| $1.86M | ﹤0.01% |
9,100
+3,200
| +54% | +$633K |
|
4447
Stoneridge
SRI
$205M
| $1.86M | ﹤0.01% |
58,957
+48,423
| +460% | +$1.43M |
|
|
RVNC
4448
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.86M | ﹤0.01% |
143,323
-63,128
| -31% | -$796K |
|
4449
CALL
Cognex
CGNX
$11B
| $1.86M | ﹤0.01% |
38,700
-2,200
| -5% | -$106K |
|
|
TPTX
4450
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.85M | ﹤0.01% |
+45,541
| New | +$1.62M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.